Newsroom

News from our partners

 This newsroom will share the latest information about anything related to narcolepsy, idiopathic hypersomnia, and sleep together with press releases from us and our partners.

07/21/22
Avadel Pharmaceuticals Explains Tentative Approval of LUMRYZ™ (sodium oxybate) in a letter to the community.

07/19/22
Avadel Pharmaceuticals Announces Tentative Approval of LUMRYZ™ (sodium oxybate) extended-release oral suspension.

Newsroom and press releases.

More to come.